20 results
DRS
VIR
Vir Biotechnology Inc
27 Jun 19
Draft registration statement
12:00am
to report information related to payments and other transfers of value to physicians and other healthcare providers, marketing expenditures or drug pricing … -funded healthcare programs, and increased governmental control of drug pricing.
There have been several U.S. government initiatives over the past few
DRS/A
VIR
Vir Biotechnology Inc
7 Aug 19
Draft registration statement (amended)
12:00am
healthcare providers, marketing expenditures or drug pricing, and state and local laws that require the registration of pharmaceutical sales representatives … and biopharmaceutical products, especially under government-funded healthcare programs, and increased governmental control of drug pricing.
There have been
10-K
2019 FY
VIR
Vir Biotechnology Inc
26 Mar 20
Annual report
4:08pm
and other transfers of value to physicians and other healthcare providers, marketing expenditures or drug pricing, and state and local laws … governmental control of drug pricing.
There have been several U.S. government initiatives over the past few years to fund and incentivize certain comparative
424B4
ennsf5fovqxsj0px
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
ihb3pivmlx19jbr3
30 Sep 19
IPO registration (amended)
6:12am
S-1
xccrlhgmqbv41u
3 Sep 19
IPO registration
4:40pm
8-K
EX-99.2
ei04dg
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
- Prev
- 1
- Next